{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:13:07Z","timestamp":1698732787310},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T00:00:00Z","timestamp":1327881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Nurse Practitioners"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Purpose:<\/jats:bold> To evaluate the role of counseling for patients undergoing screening for type 2 herpes simplex virus (HSV\u20102). Using pre\u2010 and post\u2010screening questionnaires, we evaluated correlations between demographic factors, measures of self\u2010efficacy and follow\u2010through with the screening test, and willingness to take antiviral medication and share results with sexual partners.<\/jats:p><jats:p><jats:bold>Data sources:<\/jats:bold> Subjects (<jats:italic>N<\/jats:italic>= 115) were recruited as part of usual care at a private, urban family practice. A total of 111 subjects completed pre\u2010screening questionnaires, and 38 completed post\u2010screening questionnaires.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The overwhelming majority of participants were (a) willing to undergo screening; (b) take suppressive antiviral medication if necessary; (c) share their results with sexual partners; and (d) consider safer sexual practices as a consequence of screening. Older patients were less willing to consider daily antiviral medication. Men who have sex with men (MSM) had lower perceived susceptibility to HSV\u20102 but were more likely to undergo and report screening.<\/jats:p><jats:p><jats:bold>Implications for practice:<\/jats:bold> Future research should include predictive models for determining the most appropriate patients to screen for HSV\u20102 and best practices for those who test positive. Shared decision making between patients and advanced practice nurses regarding the risks and benefits of screening for HSV\u20102 should be a component visits that include sexually transmitted disease screening. Particular attention should be paid to those at higher risk for contracting the virus, including patients with HIV and MSM.<\/jats:p>","DOI":"10.1111\/j.1745-7599.2011.00695.x","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T18:39:40Z","timestamp":1327948780000},"page":"313-323","source":"Crossref","is-referenced-by-count":1,"title":["The roles of self\u2010efficacy and pretest counseling in type 2 herpes simplex virus screening in asymptomatic adults"],"prefix":"10.1111","volume":"24","author":[{"given":"Matthew","family":"Freeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Zychowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,30]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.75.1.69"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.4278\/0890-1171-12.1.8"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008413"},{"issue":"8","key":"e_1_2_9_5_1","first-page":"1527","article-title":"Genital herpes: A review","volume":"72","author":"Beauman J. G.","year":"2005","journal-title":"American Family Physician"},{"key":"e_1_2_9_6_1","unstructured":"California Department of Health(2010). California sexually transmitted disease (STD) screening recommendations 2010. Retrieved March 3 2011 fromhttp:\/\/www.cdph.ca.gov\/pubsforms\/Guidelines\/Documents\/CA\u2010STD\u2010Screening\u2010Recommendations\u2010BW\u2010Jun\u20102011.pdf"},{"key":"e_1_2_9_7_1","volume-title":"HSV\u20102 infection as a risk factor for HIV acquisition among men who have sex with men","author":"Celum C.","year":"2002"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904849"},{"key":"e_1_2_9_9_1","volume-title":"Report of the genital herpes prevention consultants meeting","author":"Centers for Disease Control and Prevention","year":"1998"},{"key":"e_1_2_9_10_1","volume-title":"Sexually transmitted diseases surveillance, 2008","author":"Centers for Disease Control and Prevention","year":"2009"},{"key":"e_1_2_9_11_1","volume-title":"CDC analysis of national herpes prevalence","author":"Centers for Disease Control and Prevention","year":"2010"},{"key":"e_1_2_9_12_1","volume-title":"CDC study finds U.S. herpes rates remain high","author":"Centers for Disease Control and Prevention","year":"2010"},{"issue":"2","key":"e_1_2_9_13_1","first-page":"S38","article-title":"The current trend in genital herpes. Progress in prevention","volume":"21","author":"Corey L.","year":"1994","journal-title":"Sexually Transmitted Diseases"},{"key":"e_1_2_9_14_1","volume-title":"Drugstore.com","author":"Drugstore.com.","year":"2011"},{"issue":"4","key":"e_1_2_9_15_1","first-page":"259","article-title":"Patient attitudes to type specific serological tests in the diagnosis of genital herpes","volume":"73","author":"Fairley I.","year":"1997","journal-title":"Genitourin Medicine"},{"issue":"3","key":"e_1_2_9_16_1","first-page":"60","article-title":"Psychosocial issues in genital herpes management","volume":"11","author":"Green J.","year":"2004","journal-title":"Herpes"},{"issue":"1","key":"e_1_2_9_17_1","first-page":"135","article-title":"Screening for genital herpes","volume":"72","author":"Guirguis\u2010Blake J.","year":"2005","journal-title":"American Family Physician"},{"key":"e_1_2_9_18_1","volume-title":"Clinical dermatology: A color guide to diagnosis and therapy","author":"Habif T. P.","year":"2004"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012756"},{"issue":"2","key":"e_1_2_9_20_1","first-page":"48","article-title":"Expert commentary: Genital herpes transmission","volume":"11","author":"Leone P.","year":"2004","journal-title":"Herpes"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/591914"},{"issue":"2","key":"e_1_2_9_22_1","first-page":"35","article-title":"Debate: The argument against. Should every STD clinic patient be considered for type\u2010specific serological screening for HSV?","volume":"9","author":"Mindel A.","year":"2002","journal-title":"Herpes"},{"issue":"2","key":"e_1_2_9_23_1","first-page":"32","article-title":"Debate: The argument for. Should every STD clinic patient be considered for type\u2010specific serological screening for HSV?","volume":"9","author":"Patrick D. M.","year":"2002","journal-title":"Herpes"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-4-199302150-00004"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200207000-00011"},{"key":"e_1_2_9_26_1","unstructured":"University of South Florida. (2009).Sexually transmitted disease information. InU. o. S.Florida(Ed.). Miami FL :University of South Florida."},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/342104"},{"key":"e_1_2_9_28_1","unstructured":"World Health Organization. (2011).Sexually transmitted diseases: Herpes simplex type 2: Disease burden. Retrieved February 21 2011 2011 fromhttp:\/\/www.who.int\/vaccine_research\/diseases\/soa_std\/en\/index3.html"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3200\/JACH.52.5.229-236"}],"container-title":["Journal of the American Academy of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1745-7599.2011.00695.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2011.00695.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T22:51:41Z","timestamp":1698706301000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1745-7599.2011.00695.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,30]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1745-7599.2011.00695.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1745-7599.2011.00695.x","archive":["Portico"],"relation":{},"ISSN":["1041-2972","1745-7599"],"issn-type":[{"value":"1041-2972","type":"print"},{"value":"1745-7599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,30]]}}}